Prostate cancer is the second most common cancer in men. In fact, about 1 in 7 men will be diagnosed with this disease during his lifetime. However, most cases are detected in an early stage and are low-risk, posing little or no threat to the patient. KOELIS, The Prostate Care Company, proposes new concepts and guidelines in prostate care management. Based on the value of 3D imaging and KOELIS technologies, tumors can be effectively treated without affecting patients’ quality of life.